<div class="grid-row">
  <div class="column-two-thirds">
    <div class="gem-c-title
  
  gem-c-title--margin-bottom-5">
    <p class="gem-c-title__context">
      Press release
    </p>
  <h1 class="gem-c-title__text gem-c-title__text--long">
    Three further batches of blood pressure and heart medication recalled from pharmacies
  </h1>
</div>

  </div>
  
  <div class="column-two-thirds">
    
  <p class="gem-c-lead-paragraph ">
    MHRA has recalled 3 batches of Losartan tablets due to contamination with the nitrosamine N-nitroso-N-methylamino butyric acid.
  </p>

  </div>
</div>

<div class="grid-row">
  <div class="metadata-logo-wrapper">
    <div class="column-two-thirds metadata-column">
        <div class="app-c-publisher-metadata">
    <div class="app-c-published-dates ">
    Published 21 March 2019
</div>

      <div class="app-c-publisher-metadata__other">
        <dl data-module="track-click">
            <dt class="app-c-publisher-metadata__term">
              From:
            </dt>
            <dd class="app-c-publisher-metadata__definition" data-module="gem-toggle">
                <span class="app-c-publisher-metadata__definition-sentence">
                  <a href="/government/organisations/medicines-and-healthcare-products-regulatory-agency">Medicines and Healthcare products Regulatory Agency</a>
                </span>
            </dd>
        </dl>
      </div>
  </div>

    </div>
    <div class="column-one-third">
    </div>
  </div>
</div>




<div class="grid-row">
  <div class="column-two-thirds content-bottom-margin">
    <div class="responsive-bottom-margin">
      <figure class="app-c-figure">
  <img class="app-c-figure__image" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/image_data/file/85532/s300_Losartan_recall.jpg" alt="Precautionary Recall - Losartan"></img>
    <figcaption class="app-c-figure__figcaption">

    </figcaption>
</figure>

      
<div class="gem-c-govspeak govuk-govspeak direction-ltr" data-module="govspeak">
      <div class="govspeak">
<p>As a precautionary measure to protect public health, the Medicines and Healthcare products Regulatory Agency (<abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr>) today recalled 3 batches of Losartan tablets due to contamination with the nitrosamine N-nitroso-N-methylamino butyric acid (<abbr title="N-nitroso-N-methylamino butyric acid">NMBA</abbr>). The affected batches can be viewed <a href="https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-accord-healthcare-limited-losartan-potassium-50mg-film-coated-tablets-pl-20075-0022-and-losartan-potassium-100mg-film-coated-tablets-pl-20075-0023?cachebust=1553184593">here</a>.</p>

<p>The recall is taking place as part of the continued investigation into potential nitrosamine contamination of sartan containing medicines, a class of medicine to treat blood pressure and heart attacks and heart failures.</p>

<p>Currently there is no evidence that nitrosamine impurities can cause harm and patients are being advised to continue taking their medication.</p>

<p>The investigation into possible contamination of sartan medicines began in 2018, after the nitrosamine N-nitrosodimethylamine (<abbr title="N-nitrosodimethylamine">NDMA</abbr>), was identified in valsartan manufactured at a facility based in China.</p>

<p>Last year, the <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> recalled batches of valsartan containing tablets to pharmacy level in <a href="https://www.gov.uk/government/news/blood-pressure-and-heart-medication-recalled-from-pharmacies">July</a> and <a href="https://www.gov.uk/government/news/mhra-recalls-valsartan-blood-pressure-and-heart-medication-from-pharmacies">November</a> due to possible <abbr title="N-nitrosodimethylamine">NDMA</abbr> and N-nitrosodiethylamine (<abbr title="N-nitrosodiethylamine">NDEA</abbr>) contamination.</p>

<p>In <a href="https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-macleods-pharma-uk-limited-irbesartan-150mg-film-coated-tablets-pl-34771-0079-mdr-94-06-18">January</a> and <a href="https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-actavis-group-ptc-ehf-irbesartan-300mg-film-coated-tablets-pl-30306-0108-and-irbesartan-hydrochlorothiazide-300-25mg-film-coated-tablets-pl-30306-0267-mdr-94-06-18">February</a> 2019 the <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> recalled batches of irbesartan containing tablets after testing revealed possible contamination with <abbr title="N-nitrosodiethylamine">NDEA</abbr>.</p>

<p>The <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> continues to monitor the situation in the UK and are comprehensively investigating the issue alongside the European Medicines Agency (<abbr title="European Medicines Agency">EMA</abbr>) and the European Directorate for the Quality of Medicines (<abbr title="European Directorate for the Quality of Medicines">EDQM</abbr>).</p>

<p>Bernadette Sinclair-Jenkins, <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr>â€™s Manager, Regulatory Assessment Unit of the Inspection, Enforcement and Standards Division, said:</p>

<blockquote>
  <p>Our priority as regulator is to make sure the medicines you and your family take are effective and acceptably safe.</p>

  <p>This recall shows we are continuing to investigate potential contamination of sartan containing medicines.</p>

  <p>There is no evidence at present that medicines containing <abbr title="N-nitrosodimethylamine">NDMA</abbr>, <abbr title="N-nitrosodiethylamine">NDEA</abbr> or <abbr title="N-nitroso-N-methylamino butyric acid">NMBA</abbr> have caused any harm to patients and this recall is a precautionary measure.</p>

  <p>Because of the risk associated with suddenly stopping high blood pressure medication, continue to take your medicines as prescribed by your doctor.</p>

  <p class="last-child">Please speak to your doctor or pharmacist if you have any concerns about your medicine.</p>
</blockquote>

<div class="contact postal-address" id="contact_2345">
  <div class="content">
    <h3>Media enquiries</h3>

    <div class="vcard contact-inner">
        <p class="adr">
<span class="fn">News centre</span><br></br>
<span class="street-address"><abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr>
<br></br>
10 South Colonnade</span><br></br>
<span class="locality">London</span><br></br>
<span class="postal-code">E14 4PU</span>
</p>


        <div class="email-url-number">
            <p class="email">
              <span class="type">Email</span>
              <a class="email" href="mailto:newscentre@mhra.gov.uk">newscentre@mhra.gov.uk</a>
            </p>
            <p class="tel">
              <span class="type">During office hours:</span>
              020 3080 7651 (08:30 - 17:00)
            </p>
            <p class="tel">
              <span class="type">Out of office hours:</span>
              07770 446 189 (17:00 - 08:30)
            </p>
        </div>

        <p class="comments">Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at <a href="https://www.twitter.com/mhrapress">https://www.twitter.com/mhrapress</a></p>

    </div>
  </div>
</div>

</div>
</div>

    </div>

    <div class="dont-print responsive-bottom-margin">
        <div class="gem-c-share-links  " data-module="track-click">
      <h2 class="gem-c-share-links__title">Share this page</h2>

    <ul class="gem-c-share-links__list">
        <li class="gem-c-share-links__list-item">
          <a target="_blank" rel="noopener noreferrer external" data-track-category="social media" data-track-action="facebook" data-track-options="{"socialAction":"share","socialNetwork":"facebook","socialTarget":"https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2Fthree-further-batches-of-blood-pressure-and-heart-medication-recalled-from-pharmacies"}" class="gem-c-share-links__link " href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2Fthree-further-batches-of-blood-pressure-and-heart-medication-recalled-from-pharmacies">
            <span class="gem-c-share-links__link-icon">
                <svg xmlns="http://www.w3.org/2000/svg" width="32" height="32">
                  <path fill="currentColor" d="M31.006 0H.993A.997.997 0 0 0 0 .993v30.014c0 .55.452.993.993.993h30.013a.998.998 0 0 0 .994-.993V.993A.999.999 0 0 0 31.006 0z"></path>
                  <path fill="#FFF" d="M17.892 10.751h1.787V8.009L17.216 8c-2.73 0-3.352 2.045-3.352 3.353v1.828h-1.581v2.824h1.581V24h3.322v-7.995h2.242l.291-2.824h-2.533V11.52c.001-.623.415-.769.706-.769z"></path>
                </svg>

            </span><span class="visually-hidden">Share on </span>Facebook</a>
        </li>
        <li class="gem-c-share-links__list-item">
          <a target="_blank" rel="noopener noreferrer external" data-track-category="social media" data-track-action="twitter" data-track-options="{"socialAction":"share","socialNetwork":"twitter","socialTarget":"https://twitter.com/share?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2Fthree-further-batches-of-blood-pressure-and-heart-medication-recalled-from-pharmacies\u0026text=Three%20further%20batches%20of%20blood%20pressure%20and%20heart%20medication%20recalled%20from%20pharmacies"}" class="gem-c-share-links__link " href="https://twitter.com/share?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2Fthree-further-batches-of-blood-pressure-and-heart-medication-recalled-from-pharmacies&text=Three%20further%20batches%20of%20blood%20pressure%20and%20heart%20medication%20recalled%20from%20pharmacies">
            <span class="gem-c-share-links__link-icon">
                <svg xmlns="http://www.w3.org/2000/svg" width="32" height="32">
                  <path fill="currentColor" d="M31.007 0H.993A.999.999 0 0 0 0 .993v30.014c0 .55.452.993.993.993h30.014a.997.997 0 0 0 .993-.993V.993A.998.998 0 0 0 31.007 0z"></path>
                  <path fill="#FFF" d="M8 21.027a9.286 9.286 0 0 0 5.032 1.475c6.038 0 9.34-5.002 9.34-9.339 0-.143-.004-.284-.012-.425a6.619 6.619 0 0 0 1.639-1.699c-.6.265-1.234.439-1.885.516a3.287 3.287 0 0 0 1.443-1.816 6.571 6.571 0 0 1-2.086.797 3.28 3.28 0 0 0-5.592 2.993 9.311 9.311 0 0 1-6.766-3.43 3.294 3.294 0 0 0-.443 1.651 3.28 3.28 0 0 0 1.46 2.732 3.278 3.278 0 0 1-1.488-.411v.041a3.288 3.288 0 0 0 2.633 3.22 3.28 3.28 0 0 1-1.481.055 3.285 3.285 0 0 0 3.065 2.281 6.59 6.59 0 0 1-4.076 1.404A6.76 6.76 0 0 1 8 21.027z"></path>
                </svg>

            </span><span class="visually-hidden">Share on </span>Twitter</a>
        </li>
    </ul>
  </div>

    </div>

    <div class="app-c-published-dates ">
    Published 21 March 2019
</div>

  </div>

  
<div class="column-one-third">
  
<div class="gem-c-contextual-sidebar">

    


</div>

</div>

</div>


  <div class="grid-row">
    <div class="column-two-thirds">
        
  <div class="gem-c-contextual-footer">
    
  <div class="gem-c-related-navigation">





      <nav role="navigation" class="gem-c-related-navigation__nav-section" aria-labelledby="related-nav-topics-81218e2f" data-module="gem-toggle">

    <h2 id="related-nav-topics-81218e2f" class="gem-c-related-navigation__sub-heading gem-c-related-navigation__sub-heading--footer" data-track-count="footerRelatedItemSection">Explore the topic</h2>

  <ul class="gem-c-related-navigation__link-list" data-module="track-click">


        <li class="gem-c-related-navigation__link"><a class="gem-c-related-navigation__section-link gem-c-related-navigation__section-link--footer" data-track-category="relatedLinkClicked" data-track-action="1.1 Explore the topic" data-track-label="/topic/medicines-medical-devices-blood/vigilance-safety-alerts" data-track-options="{"dimension28":"1","dimension29":"Vigilance, safety alerts and guidance"}" href="/topic/medicines-medical-devices-blood/vigilance-safety-alerts">Vigilance, safety alerts and guidance</a></li>

  </ul>
</nav>

  </div>

  </div>


    </div>
  </div>